Evolocumab Biosimilar - Research Grade
Bulk Evolocumab Biosimilar - Research Grade
Product Benefits:ichorbio's Evolocumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. ichorbio: the best antibodies for in vivo research.
Size:ichorbio's research grade evolocumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our evolocumab biosimilar - please contact us for pricing.
Target:PCSK9
Clone:n/a
Isotype:IgG2
Other Names:Proprotein convertase subtilisin/kexin type 9, NARC-1, PC9
Host:Humanized
Species Reactivity:Human
Specificity:Detects human PCSK9.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Evolocumab biosimilar is a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin 9 (PCSK9). Evolocumab biosimilarhas an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, clear or milky white, colorless to pale yellow solution, containing acetic acid, Polysorbate 80 and proline. pH of the buffer is 5.0. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 0.75 EU/mg as determined by the LAL method
Storage:Evolocumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's evolocumab biosimilar is for research use only. Isotype Control:| Concentration | 9.35mg/ml |
|---|---|
| Isotype | IgG2 |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human PCSK9. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Evolocumab. |
| Species Reactivity | Human |
| Target | PCSK9 |
| Shipping Conditions | Blue ice |
| background | Evolocumab biosimilar is a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin 9 (PCSK9). Evolocumab biosimilarhas an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineere |
| Other names | Proprotein convertase subtilisin/kexin type 9, NARC-1, PC9 |
| UniProt | Q8NBP7 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |